Leidos (NYSE:LDOS – Free Report) had its target price upped by The Goldman Sachs Group from $205.00 to $228.00 in a research note published on Wednesday morning, Benzinga reports. The firm currently has a buy rating on the aerospace company’s stock.
Other analysts also recently issued reports about the company. Truist Financial upped their target price on Leidos from $165.00 to $175.00 and gave the company a “buy” rating in a research report on Thursday, September 5th. Barclays upped their price objective on shares of Leidos from $160.00 to $165.00 and gave the stock an “overweight” rating in a research report on Monday, August 5th. Royal Bank of Canada increased their price objective on shares of Leidos from $140.00 to $145.00 and gave the stock a “sector perform” rating in a research note on Wednesday, July 31st. TD Cowen boosted their target price on shares of Leidos from $155.00 to $166.00 and gave the company a “buy” rating in a research report on Wednesday, July 31st. Finally, Wells Fargo & Company increased their price target on shares of Leidos from $172.00 to $183.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 1st. Two research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $187.77.
View Our Latest Analysis on LDOS
Leidos Price Performance
Leidos (NYSE:LDOS – Get Free Report) last posted its quarterly earnings data on Tuesday, October 29th. The aerospace company reported $2.93 earnings per share for the quarter, topping the consensus estimate of $1.96 by $0.97. Leidos had a return on equity of 30.31% and a net margin of 7.37%. The firm had revenue of $4.19 billion for the quarter, compared to analysts’ expectations of $4.06 billion. During the same quarter last year, the business earned $2.03 EPS. The company’s quarterly revenue was up 6.9% compared to the same quarter last year. Equities analysts forecast that Leidos will post 10.07 EPS for the current year.
Leidos Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 31st. Stockholders of record on Monday, December 16th will be given a $0.40 dividend. The ex-dividend date is Friday, December 13th. This is a positive change from Leidos’s previous quarterly dividend of $0.38. This represents a $1.60 annualized dividend and a dividend yield of 0.87%. Leidos’s dividend payout ratio (DPR) is 17.31%.
Insider Buying and Selling
In other news, Director Robert C. Kovarik, Jr. sold 1,047 shares of the firm’s stock in a transaction that occurred on Thursday, October 31st. The shares were sold at an average price of $184.94, for a total transaction of $193,632.18. Following the completion of the sale, the director now owns 6,408 shares of the company’s stock, valued at $1,185,095.52. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. In other news, Director Gary Stephen May sold 1,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 13th. The stock was sold at an average price of $144.02, for a total transaction of $144,020.00. Following the completion of the sale, the director now owns 11,264 shares in the company, valued at $1,622,241.28. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Robert C. Kovarik, Jr. sold 1,047 shares of the stock in a transaction that occurred on Thursday, October 31st. The stock was sold at an average price of $184.94, for a total value of $193,632.18. Following the completion of the sale, the director now directly owns 6,408 shares of the company’s stock, valued at approximately $1,185,095.52. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.96% of the stock is currently owned by insiders.
Institutional Investors Weigh In On Leidos
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Northwest Investment Counselors LLC bought a new position in Leidos during the third quarter valued at about $30,000. 1832 Asset Management L.P. bought a new stake in Leidos during the 2nd quarter valued at $34,000. Blue Trust Inc. lifted its position in shares of Leidos by 251.3% during the second quarter. Blue Trust Inc. now owns 281 shares of the aerospace company’s stock worth $41,000 after acquiring an additional 201 shares in the last quarter. Kathleen S. Wright Associates Inc. bought a new position in shares of Leidos in the third quarter worth $46,000. Finally, Massmutual Trust Co. FSB ADV boosted its holdings in shares of Leidos by 122.5% in the second quarter. Massmutual Trust Co. FSB ADV now owns 307 shares of the aerospace company’s stock worth $45,000 after acquiring an additional 169 shares during the period. Hedge funds and other institutional investors own 76.12% of the company’s stock.
Leidos Company Profile
Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.
Featured Stories
- Five stocks we like better than Leidos
- How to Calculate Options Profits
- Battle of the Retailers: Who Comes Out on Top?
- Insider Selling Explained: Can it Inform Your Investing Choices?
- HCA Healthcare: Temporary Setbacks, Long-Term Strength
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- MarketBeat Week in Review – 10/28 – 11/1
Receive News & Ratings for Leidos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Leidos and related companies with MarketBeat.com's FREE daily email newsletter.